Lilly's retatrutide shows 16.8% weight loss & improved blood sugar. High potential, but watch trial risks.
Nexstar's $3.5B Tegna deal cleared by DOJ, but states and DirecTV sue to block it.
Atlas trims POR stake by $115M, but stock's up 23% YTD with a 4% dividend yield.
B2Gold (BTG) drops 8.5% on tumbling gold prices, despite 192% IPO growth. Sector peers also slide.
JPMorgan cut its S&P 500 target to 7,200, warning oil-driven price spikes from the Iran conflict are raising recession risks and hitting demand. The bank sees potential downside toward 6,000–6,200 as equities face tighter conditions.
MTA's $12B subway car order signals huge infrastructure play. Expect bids to soar!
XOM & EPD offer stable dividends (2.5%, 5.7%) amid oil volatility. Focus on long-term energy cycle survivors.
Must Read